relatório do plano de ação corretiva smeta (capr)
hora: 2022-01-05acessos: 246

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_00

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_01

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_02

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_03

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_04

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_05

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_06

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_07

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_08

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_09

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_10

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_11

todos os direitos reservados: hunan huacheng biotech, inc. adallen nutrition,inc.-mapa do site | política de privacidade | termos e condições | blogue